NCT07565363 The Effect of Motor Imagery on Upper Extremity Function in Stroke Rehabilitation
| NCT ID | NCT07565363 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital |
| Condition | Stroke Rehabilitation |
| Study Type | INTERVENTIONAL |
| Enrollment | 51 participants |
| Start Date | 2026-05-01 |
| Primary Completion | 2026-11-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 51 participants in total. It began in 2026-05-01 with a primary completion date of 2026-11-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Stroke is one of the leading causes of mortality and disability worldwide. A proportion of individuals who experience a stroke fail to achieve the desired level of motor recovery in the affected upper extremity following rehabilitation, resulting in significant limitations in activities of daily living. After stroke, rehabilitation programs are essential to reduce disability and enhance functional outcomes. This study aims to evaluate whether the addition of Motor Imagery (MI) to a standard rehabilitation program contributes to improvements in upper extremity motor function in individuals with stroke. MI is a mental practice technique in which individuals cognitively rehearse movements without physically performing them. Although the movement is not executed, the brain regions involved in the movement are activated. Eligible participants will be randomly assigned to three groups. All groups will receive a standard physical therapy and rehabilitation program. The first group will receive only standard physical therapy and rehabilitation. The second group will receive, in addition to conventional therapy, 15 minutes of MI training three days per week, while the third group will receive 15 minutes of MI training five days per week. The total treatment duration for all groups is planned as 30 sessions. Assessments will be conducted at baseline, at the end of the treatment period, and again at the 12th week. This study is based on the hypothesis that adding MI practice to a conventional upper extremity rehabilitation program after stroke will contribute to improvements in activities of daily living and functional recovery, and that these effects may be associated with the frequency of the intervention.
Eligibility Criteria
Inclusion Criteria: * Being aged 18 years or older * Having a diagnosis of ischemic or hemorrhagic stroke confirmed by computed tomography (CT) or magnetic resonance imaging (MRI) * Being in the late subacute phase (more than 3 months post-stroke) or chronic phase (more than 6 months post-stroke) following stroke onset * Presence of unilateral extremity hemiparesis * Upper extremity stage between II and V for both proximal and distal segments according to the Modified Brunnstrom Classification * A score of 21 or higher on the Mini-Mental State Examination (MMSE) Exclusion Criteria: * Severe spasticity in the affected upper extremity, defined as a Modified Ashworth Scale score \> 2 * Presence of impaired consciousness, or severe hearing, visual impairment or global aphasia. * Musculoskeletal disorders affecting upper extremity motor function, such as fracture or arthritis in the affected upper limb
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07565363 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke Rehabilitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07565363 currently recruiting?
Yes, NCT07565363 is actively recruiting participants. Contact the research team at elvangzgl@gmail.com for enrollment information.
Where is the NCT07565363 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07565363 clinical trial?
NCT07565363 is sponsored by Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital. The trial plans to enroll 51 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.